Achieve Life Sciences
ACHV
56 hedge funds and large institutions have $20.3M invested in Achieve Life Sciences in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
8% more funds holding
Funds holding: 52 → 56 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $24.1M → $20.3M (-$3.74M)
81% less call options, than puts
Call options by funds: $42K | Put options by funds: $220K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.57M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$1.16M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$811K |
| 4 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
+$332K |
| 5 |
Renaissance Technologies
New York
|
+$332K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.79M |
| 2 |
VAM
Visium Asset Management
New York
|
-$1.6M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$723K |
| 4 |
TA
Teachers Advisors
New York
|
-$443K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$341K |
ACHV Hedge Fund Activity: Q4 2014 in Review
56 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2014, worth a combined $20.3M — down 16% from $24.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ACHV positions and 6 closed out — a net gain of 5 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was BVF Inc, adding an estimated $1.57M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.79M sold.
- 56 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2014, up from 52 in Q3 2014.
- Funds reported $20.3M of Achieve Life Sciences stock for Q4 2014, down 16% quarter-over-quarter.
- 11 funds opened new Achieve Life Sciences positions in Q4 2014 and 6 closed out, a net change of +5 holders.
- The largest Achieve Life Sciences buyer in Q4 2014 was BVF Inc, an estimated $1.57M added.
- The largest Achieve Life Sciences seller in Q4 2014 was Great Point Partners, an estimated $4.79M sold.
Based on aggregated 13F filings for Q4 2014.